Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

Original Article

D. Planchard, P.A. Jänne, Y. Cheng, J.C.-H. Yang, N. Yanagitani, S.-W. Kim, S. Sugawara, Y. Yu, Y. Fan, S.L. Geater, K. Laktionov, C.K. Lee, N. Valdiviezo, S. Ahmed, J.-M. Maurel, I. Andrasina, J. Goldman, D. Ghiorghiu, Y. Rukazenkov, A. Todd, and K. Kobayashi

N Engl J Med 2023;389:1935-1948

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
11/22/2023
Course expires: 
11/23/2025
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course